It didn’t take David Systrom long to take on long COVID. Systrom – the Harvard pulmonologist whose invasive exercise tests are redefining how we think about chronic fatigue syndrome (ME/CFS) – didn’t lead this study but helped design, analyze...
An “investigational new drug” (IND) application to treat chronic fatigue syndrome (ME/CFS )and long COVID has been filed with the FDA. We don’t see INDs – the documents that begin the drug trial process at the FDA – very often in ME/CFS....
A Solve M.E.-funded project to uncover and assess the latest Long-COVID research findings made these blogs possible The goal of these continuing research reviews is to find out what researchers are learning about long COVID and how it might apply to chronic fatigue...
The big National Institutes of Health (NIH) effort on long COVID is rolling. It hasn’t come easily or quickly and the NIH has a lot of catching up to do. The world has known long COVID is a serious problem since last summer, but you wouldn’t have known it...
Bruce Patterson MD had made a lot of news with his assertion that very high levels of a chemokine called CCL5/RANTES were directing immune cells to go on the attack in long COVID. Patterson’s first study suggested that a weak adaptive immune response to the...
“We have a huge problem and a major crisis on our hands.” Avindra Nath – on long COVID – at the conference “I think the tools we’ve applied to study ME/CFS can now easily be applied to long COVID as well. And vice versa. What...
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.